A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Public ClinicalTrials.gov record NCT06693895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3a, Observer-blind, Randomized, Controlled Study to Evaluate the Safety of an Investigational Varicella Vaccine Compared With Varivax, Administered as a First Dose to Healthy Children 12 to 15 Months of Age
Study identification
- NCT ID
- NCT06693895
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 750 participants
Conditions and interventions
Conditions
Interventions
- Investigational varicella vaccine Biological
- Marketed varicella vaccine Biological
- Measles, mumps, and rubella vaccine Biological
- Hepatitis A vaccine Biological
- PCV (pneumococcal conjugate vaccine) 13 Biological
- PCV 20 Biological
- Vaxneuvance Biological
Biological
Eligibility (public fields only)
- Age range
- 12 Months to 15 Months
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2024
- Primary completion
- Nov 22, 2026
- Completion
- Nov 22, 2026
- Last update posted
- May 28, 2026
2024 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Phoenix | Arizona | 85006 | Withdrawn |
| GSK Investigational Site | Tucson | Arizona | 85741 | Withdrawn |
| GSK Investigational Site | Huntington Park | California | 90057 | Recruiting |
| GSK Investigational Site | National City | California | 91950 | Recruiting |
| GSK Investigational Site | West Covina | California | 91790 | Recruiting |
| GSK Investigational Site | Hialeah | Florida | 33012 | Recruiting |
| GSK Investigational Site | Miami | Florida | 33142 | Recruiting |
| GSK Investigational Site | Chicago | Illinois | 60621 | Recruiting |
| GSK Investigational Site | El Dorado | Kansas | 67042 | Withdrawn |
| GSK Investigational Site | Lafayette | Louisiana | 70508 | Recruiting |
| GSK Investigational Site | Mankato | Minnesota | 56002 | Recruiting |
| GSK Investigational Site | Lincoln | Nebraska | 68516 | Recruiting |
| GSK Investigational Site | Cincinnati | Ohio | 45245 | Recruiting |
| GSK Investigational Site | Dallas | Texas | 75230-2571 | Recruiting |
| GSK Investigational Site | Dallas | Texas | 75235 | Withdrawn |
| GSK Investigational Site | Houston | Texas | 77065 | Recruiting |
| GSK Investigational Site | Richmond | Texas | 77469 | Recruiting |
| GSK Investigational Site | San Antonio | Texas | 78244 | Withdrawn |
| GSK Investigational Site | Roy | Utah | 84067 | Completed |
| GSK Investigational Site | Syracuse | Utah | 84075 | Recruiting |
| GSK Investigational Site | Richmond | Virginia | 23294 | Recruiting |
| GSK Investigational Site | Vienna | Virginia | 22180 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06693895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 28, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06693895 live on ClinicalTrials.gov.